Skip to main content

MATERIALES BASADOS EN QUITOSANOS HEPARA(I)NIZADOS: MODIFICACIONES SELECTIVAS PARA NUEVAS APLICACIONES BIOMEDICAS

PID2019-105337RB-C21

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 15
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Interfering with mRNA Methylation by the 2′O-Methyltransferase (NSP16) from SARS-CoV-2 to Tackle the COVID-19 Disease

  • Morales, Paula
  • Curtis, Natalie L.
  • Zárate, Sandra G.
  • Bastida, Agatha
  • Bolanos-Garcia, Victor M.
© 2020 by the authors., The pandemic associated to Severe Acute Respiratory Syndrome Coronavirus type 2 (SARS-CoV-2) has resulted in a huge number of deaths and infected people. Although several vaccine programmes are currently underway and have reached phase 3, and a few small size drugs repurposed to aid treatment of severe cases of COVID-19 infections, effective therapeutic options for this disease do not currently exist. NSP16 is a S-adenosyl-L-Methionine (SAM) dependent 2′O-Methyltransferase that converts mRNA cap-0 into cap-1 structure to prevent virus detection by cell innate immunity mechanisms. NSP16 methylates the ribose 2′O-position of the first nucleotide of the mRNA only in the presence of an interacting partner, the protein NSP10. This feature suggests that inhibition of the NSP16 may represent a therapeutic window to treat COVID-19. To test this idea, we performed comparative structural analyses of the NSP16 present in human coronaviruses and developed a sinefungin (SFG) similarity-based virtual screening campaign to assess the druggability of the SARS-CoV-2 NSP16 enzyme. Through these studies, we identified the SFG analogue 44601604 as a promising more potent inhibitor of NSP16 to limit viral replication in infected cells, favouring viral clearance., This research was funded by CSIC (CSIC-COV19-013) and MICINN (PID2019-105337RB-C21)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Deciphering Structural Determinants in Chondroitin Sulfate Binding to FGF‐2: Paving the Way to Enhanced Predictability of their Biological Functions

  • Vessella , Giulia
  • Vázquez, José Antonio
  • Valcárcel Barros, Jesús
  • Lagartera, Laura
  • Monterrey, Dianélis T.
  • Bastida, Agatha
  • García-Junceda, Eduardo
  • Bedini, Emiliano
  • Fernández-Mayoralas, Alfonso
  • Revuelta, Julia
Controlling chondroitin sulfates (CSs) biological functions to exploit their interesting potential biomedical applications requires a comprehensive understanding of how the specific sulfate distribution along the polysaccharide backbone can impact in their biological activities, a still challenging issue. To this aim, herein, we have applied an “holistic approach” recently developed by us to look globally how a specific sulfate distribution within CS disaccharide epitopes can direct the binding of these polysaccharides to growth factors. To do this, we have analyzed several polysaccharides of marine origin and semi‐synthetic polysaccharides, the latter to isolate the structure‐activity relationships of their rare, and even unnatural, sulfated disaccharide epitopes. SPR studies revealed that all the tested polysaccharides bind to FGF‐2 (with exception of CS‐8, CS‐12 and CS‐ 13) according to a model in which the CSs first form a weak complex with the protein, which is followed by maturation to tight binding with kD ranging affinities from ~ 1.31 M to 130 M for the first step and from ~ 3.88 M to 1.8 nM for the second one. These binding capacities are, interestingly, related with the surface charge of the 3D‐structure that is modulated by the particular sulfate distribution within the disaccharide repeating‐units., This research was funded by AEI (MICINN) and FEDER (Project PID2019‐105337RB‐C21) and by MIUR (Project FFABR2017). JAV and JV also want to thank to Xunta de Galicia (Grupos de Potencial Crecimiento, IN607B 2018/19) for the financial support of this investigation, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Heparanized chitosans: towards the third generation of chitinous biomaterials

  • Revuelta, Julia
  • Fraile, Isabel
  • Toledo Monterrey, Dianelis
  • Peña, Nerea
  • Benito-Arenas, Raúl
  • Bastida, Agatha
  • Fernández-Mayoralas, Alfonso
  • García-Junceda, Eduardo
The functionalization of chitosans is an emerging research area in the design of solutions for a wide range of biomedical applications. In particular, the modification of chitosans to incorporate sulfate groups has generated great interest since they show structural similarity to heparin and heparan sulfates. Most of the biomedical applications of heparan sulfates are derived from their ability to bind different growth factors and other proteins, as through these interactions they can modulate the cellular response. This review aims to summarize the most recent advances in the synthesis, and structural and physicochemical characterization of heparanized chitosan, a remarkably interesting family of polysaccharides that have demonstrated the ability to mimic heparan sulfates as ligands for different proteins, thereby exerting their biological activity by mimicking the function of these glycosaminoglycans., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Preparation and Characterization of Aminoglycoside-Loaded Chitosan/Tripolyphosphate/Alginate Microspheres against E. coli.

  • Estefanía Tiburcio
  • García-Junceda, Eduardo
  • Garrido, Leoncio
  • Fernández-Mayoralas, Alfonso
  • Revuelta, Julia
  • Bastida, Agatha
Although aminoglycosides are one of the common classes of antibiotics that have been widely used for treating infections caused by pathogenic bacteria, the evolution of bacterial resistance mechanisms and their inherent toxicity have diminished their applicability. Biocompatible carrier systems can help sustain and control the delivery of antibacterial compounds while reducing the chances of antibacterial resistance or accumulation in unwanted tissues. In this study, novel chitosan gel beads were synthesized by a double ionic co-crosslinking mechanism. Tripolyphosphate and alginate, a polysaccharide obtained from marine brown algae, were employed as ionic cross-linkers to prepare the chitosan-based networks of gel beads. The in vitro release of streptomycin and kanamycin A was bimodal; an initial burst release was observed followed by a diffusion mediated sustained release, based on a Fickian diffusion mechanism. Finally, in terms of antibacterial properties, the particles resulted in growth inhibition of Gram-negative (E. coli) bacteria., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Chitosan sulfate-lysozyme hybrid hydrogels as platforms with fine-tuned degradability and sustained inherent antibiotic and antioxidant activities

  • Aguanell, Antonio
  • Pozo, María Luisa del
  • Pérez-Martín, Carlos
  • Pontes, Gabriela
  • Bastida, Agatha
  • Fernández-Mayoralas, Alfonso
  • García-Junceda, Eduardo
  • Revuelta, Julia
The control of the properties and biological activities of chitosan-lysozyme hybrid hydrogels to exploit their interesting biomedical applications depends largely on the chitosan acetylation pattern, a difficult parameter to control. Herein, we have prepared sulfated chitosan-lysozyme hydrogels as versatile platforms with fine-tuned degradability and persistent bactericidal and antioxidant properties. The use of chitosan sulfates instead of chitosan has the advantage that the rate and mechanisms of lysozyme release, as well as antibacterial and antioxidant activities, depend on the sulfation profile, a structural parameter that is easily controlled by simple chemical modifications. Thus, while 6-O-sulfated chitosan hydrogels allow the release of loaded lysozyme in a short time (60% in 24 h), due to a high rate of degradation that allows rapid antibiotic and antioxidant activities, in 3-O-sulfated systems there is a slow release of lysozyme (80% in 21 days), resulting in long-lasting antibiotic and antioxidant activities., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Design and biocatalytic applications of genetically fused multifunctional enzymes

  • Monterrey, Dianélis T.
  • Ayuso-Fernández, Iván
  • Oroz-Guinea, Isabel
  • García-Junceda, Eduardo
Fusion proteins, understood as those created by joining two or more genes that originally encoded independent proteins, have numerous applications in biotechnology, from analytical methods to metabolic engineering. The use of fusion enzymes in biocatalysis may be even more interesting due to the physical connection of enzymes catalyzing successive reactions into covalently linked complexes. The proximity of the active sites of two enzymes in multi-enzyme complexes can make a significant contribution to the catalytic efficiency of the reaction. However, the physical proximity of the active sites does not guarantee this result. Other aspects, such as the nature and length of the linker used for the fusion or the order in which the enzymes are fused, must be considered and optimized to achieve the expected increase in catalytic efficiency. In this review, we will relate the new advances in the design, creation, and use of fused enzymes with those achieved in biocatalysis over the past 20 years. Thus, we will discuss some examples of genetically fused enzymes and their application in carbon‑carbon bond formation and oxidative reactions, generation of chiral amines, synthesis of carbohydrates, biodegradation of plant biomass and plastics, and in the preparation of other high-value products., The authors gratefully acknowledge the financial support provided by MINECO/FEDER (Grant MAT2015-65184-C2-2-R) and MICIN/ FEDER (Grant PID2019-105337RB-C21). I. O.-G., acknowledge the CSIC for a JAE Predoctoral contract program cofounded by ESF (European Social Fund). We thank the reviewers for their helpful comments., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Identification of Novel Potential Heparanase Inhibitors Using Virtual Screening

  • Rus, A.
  • Bolanos-Garcia, Victor M.
  • Bastida, Agatha
  • Morales, Paula
Heparanase (HPSE) is a mammalian endo-β-D-glucuronidase that cleaves heparan sulphate (HS) side chains of heparin sulphate proteoglycans (HSPG), a class of molecules composed of repeat-ing polysulfated disaccharide units of glucosamine and hexuronic acid residues. HPSE controls the availability of growth factors, chemokines, lipoproteins and other bioactive molecules by degrading HS into smaller fractions, allowing the release of saccharide fragments that activate a plethora of signaling processes. HPSE overexpression has been correlated with tumor survival and metastasis as well as several diseases associated with chronic inflammation, including the ongoing COVID-19 pandemic caused by SARS-CoV-2. Thus, the search for molecules that could potentially inhibit HPSE has become increasingly relevant in the clinic. In this study, we have integrated a strategy that combines virtual screening and molecular docking of publicly available chemical databases to identify small compounds that can be developed into novel HPSE inhibitors. Structural rationalization of the interactions previously reported compounds led us to identify promising unexplored chemotypes. Here we show that these novel potential HPSE inhibitors present optimized in silico druggability and docking properties and may serve as pharmacological tools for the treatment of chronic and infectious diseases associated with chronic inflammation., This research was funded by Ministerio de Economia Industria y Competitividad grant number PID2019-105337RB-C21 and the state agency Spanish national research council (CSIC), Program i-LINK (LINKB20075)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Fast and Sustained Axonal Growth by BDNF Released from Chitosan Microspheres

  • Aranaz, Inmaculada
  • Acosta, Niuris
  • Revuelta, Julia
  • Bastida, Agatha
  • Gómez-Casado, Víctor
  • Civera, Concepción
  • Garrido, Leoncio
  • García-Junceda, Eduardo
  • Heras, Ángeles
  • Alcántara, Andrés R.
  • Fernández-Mayoralas, Alfonso
  • Doncel-Pérez, Ernesto
Brain-derived neurotrophic factor (BDNF) regulates dendritic branching and dendritic spine morphology, as well as synaptic plasticity and long-term potentiation. Consequently, BDNF deficiency has been associated with some neurological disorders such as Alzheimer’s, Parkinson’s or Huntington’s diseases. In contrast, elevated BDNF levels correlate with recovery after traumatic central nervous system (CNS) injuries. The utility of BDNF as a therapeutic agent is limited by its short half-life in a pathological microenvironment and its low efficacy caused by unwanted consumption of non-neuronal cells or inappropriate dosing. Here, we tested the activity of chitosan microsphere-encapsulated BDNF to prevent clearance and prolong the efficacy of this neurotrophin. Neuritic growth activity of BDNF release from chitosan microspheres was observed in the PC12 rat pheochromocytoma cell line, which is dependent on neurotrophins to differentiate via the neurotrophin receptor (NTR). We obtained a rapid and sustained increase in neuritic out-growth of cells treated with BDNF-loaded chitosan microspheres over control cells (<i>P</i> < 0.001). The average of neuritic out-growth velocity was three times higher in the BDNF-loaded chitosan microspheres than in the free BDNF. We conclude that the slow release of BDNF from chitosan microspheres enhances signaling through NTR and promotes axonal growth in neurons, which could constitute an important therapeutic agent in neurodegenerative diseases and CNS lesions., Financial support was provided by the Ministerio de Ciencia, Innovación y Universidades, Grants PID2019-105337RB-C21 and PID2019-105337RB-C22 and co-financed by European Union (FEDER), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Design of a biocatalytic cascade for the enzymatic sulfation of unsulfated chondroitin with in situ generation of PAPS

  • Dianelis T. Monterrey
  • Raúl Benito-Arenas
  • Revuelta, Julia
  • García-Junceda, Eduardo
Sulfation of molecules in living organisms is a process that plays a key role in their functionality. In mammals, the sulfation of polysaccharides (glycosaminoglycans) that form the proteoglycans present in the extracellular matrix is particularly important. These polysaccharides, through their degree and sulfation pattern, are involved in a variety of biological events as signal modulators in communication processes between the cell and its environment. Because of this great biological importance, there is a growing interest in the development of efficient and sustainable sulfation processes, such as those based on the use of sulfotransferase enzymes. These enzymes have the disadvantage of being 3′-phosphoadenosine 5′-phosphosulfate (PAPS) dependent, which is expensive and difficult to obtain. In the present study, a modular multienzyme system was developed to allow the in situ synthesis of PAPS and its coupling to a chondroitin sulfation system. For this purpose, the bifunctional enzyme PAPS synthase 1 (PAPSS1) from Homo sapiens, which contains the ATP sulfurylase and APS kinase activities in a single protein, and the enzyme chondroitin 4-O-sulfotransferase (C4ST-1) from Rattus norvegicus were overexpressed in E. coli. The product formed after coupling of the PAPS generation system and the chondroitin sulfation module was analyzed by NMR., This research was funded by AEI (MICINN) and FEDER, grant number PID2019-105337RB-C21, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

From the problem to the solution: Chitosan valorization cycle

  • Irene Junceda-Mena
  • García-Junceda, Eduardo
  • Revuelta, Julia
The problem of fisheries waste has increased in recent years and has become a global problem influenced by various biological, technical, operational and socioeconomic factors. In this context, the use of these residues as raw materials is a proven approach not only to reduce the crisis of unprecedented magnitude facing the oceans, but also to improve the management of marine resources and increase the competitiveness of the fisheries sector. However, the implementation of valorization strategies at the industrial level is being excessively slow, despite this great potential. Chitosan, a biopolymer extracted from shellfish waste, is a clear example of this because although countless chitosan-based products have been described for a wide variety of applications, commercial products are still limited. To address this drawback, it is essential to consolidate a “bluer” chitosan valorization cycle towards sustainability and circular economy. In this perspective we wanted to focus on the cycle of valorization of chitin, which allows to transform a waste product (chitin) into a material suitable for the development of useful products to solve the source of its origin as a waste product and pollutant; chitosan-based membranes for wastewater remediation., Financial support provided by the grant PID2019-105337RB-C21 (MICIN/FEDER), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Synthetic heparan sulfate mimics based on chitosan derivatives show broad-spectrum antiviral activity

  • Geller, Ron
  • Revuelta, Julia
  • Rusu, Luciana
  • Francés-Gómez, Clara
  • Trapero, Elena
  • Iglesias, Susana
  • Calvo Pinilla, Eva
  • Blázquez, Ana-Belén
  • Gutiérrez-Adán, Alfonso
  • Konuparamban, Acsah
  • Moreno, Oscar
  • Gómez-Martínez, María
  • Forcada-Nadal, Alicia
  • López-Redondo, Marisa
  • Llácer, José Luis
  • Llop, Jordi
  • Martín-Acebes, M. A.
  • Fernández-Mayoralas, Alfonso
Enveloped viruses enter cells by binding to receptors present on host cell membranes, which trigger internalization and membrane fusion. For many viruses, this either directly or indirectly involves interaction with membrane-anchored carbohydrates, such as heparan sulfate, providing a potential target for a broad-spectrum antiviral approach. Based on this hypothesis, we screened a library of functionalized chitosan sulfates that mimic heparan sulfate in cellular membranes for inhibition of SARS-CoV-2 and respiratory syncytial virus (RSV) entry. An array of compounds blocking SARS-CoV-2 and RSV were identified, with the lead compound displaying broad-spectrum activity against multiple viral strains and clinical isolates. Mechanism of action studies showed the drug to block viral entry irreversibly, likely via a virucidal mechanism. Importantly, the drug was non-toxic in vivo and showed potent post-exposure therapeutic activity against both SARS-CoV-2 and RSV. Together, these results highlight the potential of functionalized carbohydrates as broad-spectrum antivirals targeting respiratory viruses., Funding for this project was provided by grants SGL2021-03-009, SGL2103053, and SGL2021-03-052 from European Union NextGenerationEU/PRTR through the CSIC Global Health Platform established by EU Council Regulation 2020/2094, to RG, to MAM-A, J. R., A. F.-M., J.L.L, and the IBV-Covid19-Pipeline acknowledge the financial support provided by CSIC (grants CSIC-COV19-013, CSIC-COV19-082) and the MICIN (grants PID2019-105337RB-C21, PID2020-120322RB-C21, PID2020-116880GB-I00). RG also acknowledges funding from the Generalitat Valenciana (GVA, GVCOVID19-2020-05). MAM-A acknowledges funding from the European Union’s Horizon Europe research and innovation programme under grant agreement number 101137506 (NAVIPP)., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Lysozyme-Responsive Hydrogels of Chitosan-Streptomycin Conjugates for the On-Demand Release of Biofilm-Dispersing Enzymes for the Efficient Eradication of Oral Biofilms

  • Pozo, María Luisa del
  • Aguanell, Antonio
  • García-Junceda, Eduardo
  • Revuelta, Julia
Published as part of Chemistry of Materials special issue “Polymer-Drug Conjugate Materials”., Hydrogels with controlled degradation and sustained antibiofilm activity are promising biomaterials for the treatment of oral infections such as periodontitis or caries. In this article, an in situ forming chitosan-streptomycin hydrogel is developed that can target established bacterial biofilms in response to lysozyme, an enzyme that is overexpressed in saliva during oral infections. When the new hydrogel is applied to simulated oral biofilms, the overexpressed lysozyme degrades the hydrogel and releases chitosan-streptomycin oligosaccharides that can eradicate the biofilm. This work has shown that the coupling of chitosan and streptomycin can have a synergistic effect and that the new hydrogel based on chitosan-streptomycin conjugate can effectively combat biofilms of E. coli, S. aureus, and P. aeruginosa formed in vitro achieving a significant reduction in the biomass of the biofilm and a substantial reduction in the population of viable bacteria in established biofilms. Finally, the CS-Str hydrogel loaded with biofilm-disrupting enzymes, in particular, DNase I and/or DspB, showed a significantly increased ability to reduce the biofilm biomass of P. aeruginosa and S. aureus (by over 84% and up to 92%, respectively), resulting in a drastic reduction in cell viability, which fell below 4% for P. aeruginosa and below 5% for S. aureus., This publication is part of the grant PID2019-105337RB-C21,funded by MICIN/AEI/10.13039/501100011033 and by“ERDF A way of making Europe”, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Polyphosphate Kinase from Burkholderia cenocepacia, One Enzyme Catalyzing a Two-Step Cascade Reaction to Synthesize ATP from AMP

  • Monterrey, Dianélis T.
  • Azcona, Leire
  • Revuelta, Julia
  • Sánchez-Moreno, Israel
  • García-Junceda, Eduardo
This study characterizes a novel polyphosphate kinase from Burkholderia cenocepacia (BcPPK2-III), an enzyme with potential applications in ATP regeneration processes. Bioinformatic and structural analyses confirmed the presence of conserved motifs characteristic of PPK2 enzymes, including Walker A and B motifs, and the subclass-specific residue E137. Molecular docking simulations showed AMP had the highest binding affinity (−7.0 kcal/mol), followed by ADP (−6.5 kcal/mol), with ATP having the lowest affinity (−6.3 kcal/mol). It was overexpressed in Escherichia coli, after purification enzymatic activity assays revealed that BcPPK2-III needed divalent cations (Mg2⁺, Mn2⁺, Co2⁺) as cofactors to be active. Functional assays revealed its ability to synthesize ATP from AMP through a stepwise phosphorylation mechanism, forming ADP as an intermediate, achieving 70% ATP conversion (TTN 4354.7) after 24 h. Kinetic studies indicated cooperative behavior and substrate preference, with AMP phosphorylation to ADP being the most efficient step. The enzyme demonstrated high thermostability (T50 = 62 °C) and a broad pH stability range (pH 6.0–9.0), making it suitable for diverse biocatalytic applications. The study highlights BcPPK2-III as a robust and versatile candidate for cost-effective ATP regeneration, offering advantages in industrial processes requiring stoichiometric amounts of ATP., This research was funded by MICIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”, grant number PID2019-105337RB-C21., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Synthetic heparan sulfate mimics based on chitosan derivatives show broad-spectrum antiviral activity

  • Revuelta, Julia
  • Rusu, Luciana
  • Francés-Gómez, Clara
  • Trapero, Elena
  • Iglesias, Susana
  • Pinilla, Eva Calvo
  • Blázquez, Ana-Belén
  • Gutiérrez-Adán, Alfonso
  • Konuparamban, Acsah
  • Moreno, Oscar
  • Gómez Martínez, María
  • Forcada-Nadal, Alicia
  • López-Redondo, Marisa
  • Avilés-Alía, Ana Isabel
  • Llácer, José Luis
  • Llop, Jordi
  • Martín-Acebes, M. A.
  • Geller, Ron
  • Fernández-Mayoralas, Alfonso
Enveloped viruses enter cells by binding to receptors present on host cell membranes, which trigger internalization and membrane fusion. For many viruses, this either directly or indirectly involves interaction with membrane-anchored carbohydrates, such as heparan sulfate, providing a potential target for a broad-spectrum antiviral approach. Based on this hypothesis, we screened a library of functionalized chitosan sulfates that mimic heparan sulfate in cellular membranes for inhibition of SARS-CoV-2 and respiratory syncytial virus (RSV) entry. An array of compounds blocking SARS-CoV-2 and RSV were identified, with the lead compound displaying broad-spectrum activity against multiple viral strains and clinical isolates. Mechanism of action studies showed the drug to block viral entry irreversibly, likely via a virucidal mechanism. Importantly, the drug was non-toxic in vivo and showed potent post-exposure therapeutic activity against both SARS-CoV-2 and RSV. Together, these results highlight the potential of functionalized carbohydrates as broad-spectrum antivirals targeting respiratory viruses., This work acknowledges the use of ICTS-ReDIB, supported by the Ministry of Science, Innovation and Universities (MICIU) at biomaGUNE. We thank Raquel Palao (ICTP-CSIC) for the GPC analysis. Funding for this project was provided by grants SGL2021-03-009, SGL2103053, and SGL2021-03-052 from European Union NextGenerationEU/PRTR through the CSIC Global Health Platform established by EU Council Regulation 2020/2094, to RG, to MAM-A, J. R., A. F.-M., J.L.L, and the IBV-Covid19-Pipeline acknowledge the financial support provided by CSIC (grants CSIC-COV19-013, CSIC-COV19-082) and the MICIN (grants PID2019-105337RB-C21, PID2020-120322RB-C21, PID2020-116880GB-I00). RG also acknowledges funding from the Generalitat Valenciana (GVA, GVCOVID19-2020-05). MAM-A acknowledges funding from the European Union’s Horizon Europe research and innovation program under grant agreement number 101137506 (NAVIPP)., Peer reviewed
Docta Complutense
Publication Artículo científico (JournalArticle)

Fast and Sustained Axonal Growth by BDNF Released from Chitosan Microspheres

  • Aranaz Corral, Inmaculada
  • Acosta Contreras, Florentina Niuris
  • Revuelta Crespo, Julia
  • Bastida Codina, Agatha
  • Gómez Casado, Víctor
  • Civera Tejuca, María Concepción
  • Garrido Fernández, Leoncio
  • García Junceda, Eduardo
  • Heras Caballero, Ángeles María
  • Alcántara León, Andrés Rafael
  • Fernández Mayoralas, Alfonso
  • Doncel Pérez, Ernesto
Brain-derived neurotrophic factor (BDNF) regulates dendritic branching and dendritic spine morphology, as well as synaptic plasticity and long-term potentiation. Consequently, BDNF deficiency has been associated with some neurological disorders such as Alzheimer’s, Parkinson’s or Huntington’s diseases. In contrast, elevated BDNF levels correlate with recovery after traumatic central nervous system (CNS) injuries. The utility of BDNF as a therapeutic agent is limited by its short half-life in a pathological microenvironment and its low efficacy caused by unwanted consumption of non-neuronal cells or inappropriate dosing. Here, we tested the activity of chitosan microsphere-encapsulated BDNF to prevent clearance and prolong the efficacy of this neurotrophin. Neuritic growth activity of BDNF release from chitosan microspheres was observed in the PC12 rat pheochromocytoma cell line, which is dependent on neurotrophins to differentiate via the neurotrophin receptor (NTR). We obtained a rapid and sustained increase in neuritic out-growth of cells treated with BDNF-loaded chitosan microspheres over control cells (p < 0.001). The average of neuritic out-growth velocity was three times higher in the BDNF-loaded chitosan microspheres than in the free BDNF. We conclude that the slow release of BDNF from chitosan microspheres enhances signaling through NTR and promotes axonal growth in neurons, which could constitute an important therapeutic agent in neurodegenerative diseases and CNS lesions